^
Dropplex c-Met Exon14 Skipping Test is for non- small cell lung cancer (NSCLC, Non-Small Cell Lung Cancer) patients, in the presence of cMET Exon14 Skipping mutation by using RNA extracted from the patient's FFPE and whole blood. The test results can help with the selection of patients receiving ABN401, a targeted treatment.
Cancer:
Non Small Cell Lung Cancer
Gene:
MET (MET proto-oncogene, receptor tyrosine kinase)
Drug:
vabametkib (ABN401)
Method:
PCR
Approvals
Date
Cancer
Gene
Drug
By
04/21/22
CE